Tuberculosis dissemination in kidney transplant recipient treated with anti-CD40 monoclonal antibody: a case report
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F22%3A00083317" target="_blank" >RIV/00023001:_____/22:00083317 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11110/22:10446701 RIV/00064190:_____/22:N0000016
Výsledek na webu
<a href="https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-022-02916-2" target="_blank" >https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-022-02916-2</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1186/s12882-022-02916-2" target="_blank" >10.1186/s12882-022-02916-2</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Tuberculosis dissemination in kidney transplant recipient treated with anti-CD40 monoclonal antibody: a case report
Popis výsledku v původním jazyce
Background Tuberculosis (TBC) in solid organ transplant recipients represents a severe complication. The incidence among transplant recipients is higher than in the general population, and the diagnosis and treatment remain challenging. We present a case of active disseminated tuberculosis in a kidney transplant recipient treated with an anti-CD40 monoclonal antibody, who had been previously exposed to an active form of the disease, but latent tuberculosis (LTBI) was repeatedly ruled out prior to transplantation. To the best of our knowledge, no other case has been reported in a patient treated with the anti-CD40 monoclonal antibody. Case presentation A 49-year-old patient, 1.5 years after primary kidney transplantation, presented with vocal cord problems, a dry irritating cough, and a sore throat. A detailed investigation, including a high-resolution chest CT scan, revealed the diagnosis of disseminated tuberculosis. The antituberculosis treatment consisting of rifampicin, isoniazid, pyrazinamide, and ethambutol was started immediately. The patient's condition became complicated by relapsing diarrhoea. The colonoscopy revealed a circular stenosis above Bauhin's valve. Microscopical findings showed active colitis and vaguely formed collections of epithelioid macrophages without fully developed caseous granulomas and were consistent with the clinical diagnosis of tuberculosis. The antituberculosis treatment was subsequently enhanced by moxifloxacin and led to a great improvement in the patient's condition. Conclusion In this case, false negativity of interferon-gamma release assays and possibly higher risk for intracellular infections in patients on costimulatory signal blockers are discussed.
Název v anglickém jazyce
Tuberculosis dissemination in kidney transplant recipient treated with anti-CD40 monoclonal antibody: a case report
Popis výsledku anglicky
Background Tuberculosis (TBC) in solid organ transplant recipients represents a severe complication. The incidence among transplant recipients is higher than in the general population, and the diagnosis and treatment remain challenging. We present a case of active disseminated tuberculosis in a kidney transplant recipient treated with an anti-CD40 monoclonal antibody, who had been previously exposed to an active form of the disease, but latent tuberculosis (LTBI) was repeatedly ruled out prior to transplantation. To the best of our knowledge, no other case has been reported in a patient treated with the anti-CD40 monoclonal antibody. Case presentation A 49-year-old patient, 1.5 years after primary kidney transplantation, presented with vocal cord problems, a dry irritating cough, and a sore throat. A detailed investigation, including a high-resolution chest CT scan, revealed the diagnosis of disseminated tuberculosis. The antituberculosis treatment consisting of rifampicin, isoniazid, pyrazinamide, and ethambutol was started immediately. The patient's condition became complicated by relapsing diarrhoea. The colonoscopy revealed a circular stenosis above Bauhin's valve. Microscopical findings showed active colitis and vaguely formed collections of epithelioid macrophages without fully developed caseous granulomas and were consistent with the clinical diagnosis of tuberculosis. The antituberculosis treatment was subsequently enhanced by moxifloxacin and led to a great improvement in the patient's condition. Conclusion In this case, false negativity of interferon-gamma release assays and possibly higher risk for intracellular infections in patients on costimulatory signal blockers are discussed.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30217 - Urology and nephrology
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2022
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
BMC nephrology [online]
ISSN
1471-2369
e-ISSN
1471-2369
Svazek periodika
23
Číslo periodika v rámci svazku
1
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
6
Strana od-do
"art. no. 290"
Kód UT WoS článku
000842034300001
EID výsledku v databázi Scopus
2-s2.0-85136961989